Helminthiasis
30
2
2
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
2 terminated out of 30 trials
91.7%
+5.2% vs benchmark
17%
5 trials in Phase 3/4
14%
3 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (30)
Host Response to Infection and Treatment in Filarial Diseases
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets
Co-administration of IVM and ALB in School-based Deworming in Uganda
Assessment of Drug Efficacy of Local Albendazole
Urine Albendazole Levels for Coverage Assessment
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients
The Longevity of Trichuris Trichiura Colonization
Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education
Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
The Effect of an Urban Sanitation Intervention on Child Health
Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya
Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)
Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health
Design and Clinical Evaluation of a School Meal With Deworming Properties
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
Taenia Solium Control Case Study in Zambia
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression